Patient engagement is one of the most reliable ways to drive long-term health outcomes and a critical benchmark for ...

It is hoped the new formulation will offer patients greater freedom and flexibility compared to the liquid version ...

Apogee Therapeutics has shared positive 16-week results from a mid-stage study of its investigational anti-IL-13 antibody in ...

Japan’s evolving approach to market access includes a formal cost-effectiveness analysis (CEA) requirement for certain new ...

Eli Lilly has shared positive top-line results from a head-to-head study of its non-covalent Bruton’s tyrosine kinase (BTK) ...

AstraZeneca (AZ) has announced that Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) has been recommended by ...

Patient activation is people’s knowledge, skills, confidence and willingness to manage their own health and care. Increasing ...

Bristol Myers Squibb (BMS) and Bain Capital have created an independent biopharmaceutical company to develop immunology ...

The European Medicines Agency’s human medicines committee has recommended that BeOne Medicines’ Tevimbra (tislelizumab) be ...

Biogen’s Qalsody (tofersen) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the first ...

But while an improved reputation can be a by-product of patient engagement, it should not be the driving force behind it.

Eli Lilly’s Alzheimer’s disease (AD) drug donanemab has been recommended by the European Medicines Agency’s human medicines ...